Dan Spivak is an accomplished professional with significant experience in the pharmaceutical and healthcare sectors. Currently serving as the Franchise Head for Alpha-1 at Takeda since July 2016, Dan has held various leadership roles including Senior Director of Alpha-1 and MMN Marketing and Director of US Immunology Institutional Marketing. Prior to Takeda, Dan was with Baxalta, where responsibilities included Director of US B2B Deal Evaluations and Senior Finance Manager for US Immunology. Dan's career began at Baxter International Inc., progressing from Financial Analyst to Finance Manager in key areas such as Business Separation and Global Hemophilia. Academic credentials include an MBA from Northwestern University's Kellogg School of Management and a B.S. in Finance from the University of Illinois Urbana-Champaign.